L948-0205 Screening compound: N-(2-{2-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl}-2-oxoethyl)-2,2-diphenylacetamide

L948-0205 Screening compound: N-(2-{2-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl}-2-oxoethyl)-2,2-diphenylacetamide
L948-0205 Screening compound: N-(2-{2-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl}-2-oxoethyl)-2,2-diphenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L948-0205
N-(2-{2-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl}-2-oxoethyl)-2,2-diphenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L948-0205

Molecular Formula

C29H28N4O3 (C29 H28 N4 O3)

Compound Name

N-(2-{2-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]pyrrolidin-1-yl}-2-oxoethyl)-2,2-diphenylacetamide

IUPAC name

N-(2-{2-[3-(4-methylphenyl)-124-oxadiazol-5-yl]pyrrolidin-1-yl}-2-oxoethyl)-22-diphenylacetamide

SMILES

Cc(cc1)ccc1-c1noc(C(CCC2)N2C(CNC(C(c2ccccc2)c2ccccc2)=O)=O)n1

InChI

InChI=1S/C29H28N4O3/c1-20-14-16-23(17-15-20)27-31-29(36-32-27)24-13-8-18-33(24)25(34)19-30-28(35)26(21-9-4-2-5-10-21)22-11-6-3-7-12-22/h2-7,9-12,14-17,24,26H,8,13,18-19H2,1H3,(H,30,35)/t24-/m0/s1

InChI Key

YQUHVPCEEOIPJH-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD27488984

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

480.57

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.140

Distribution Coefficient, logD

5.140

Water Solubility, LogSw

-5.03

Polar Surface Area

72.238

Acid Dissociation Constant (pKa)

11.80

Base Dissociation Constant (pKb)

-2.75

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

24.10

L948-0205 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • Proteases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with L948-0205 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L948-0205?
Check Price and Availability of L948-0205, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L948-0205 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L948-0205
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L948-0205
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L948-0205 available by request